Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria

Published:2021-03 Issue:3 Volume:9 Page:1166-1176.e8
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Oda Yoshiko,Fukunaga Atsushi,Washio Ken,Imamura Shinya,Mizuno Mayuko,Hatakeyama Mayumi,Ogura Kanako,Nishigori Chikako

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference39 articles.

1. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria;Zuberbier;Allergy,2018

2. Serum and cell bound IgE in chronic urticaria;Greaves;Clin Allergy,1974

3. Defective histamine release in chronic urticaria;Kern;J Clin Invest,1976

4. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies;Eckman;J Invest Dermatol,2008

5. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria;Vonakis;J Allergy Clin Immunol,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of ELR, PLR, NLR and BLR Ratios during Omalizumab Treatment of Chronic Spontaneous Urticaria;Journal of Clinical Medicine;2024-07-23

2. Biomarkers for Short-Term Omalizumab Response in Chronic Spontaneous Urticaria;Annals of Dermatology;2024

3. Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria;Journal of the European Academy of Dermatology and Venereology;2023-09-09

4. ¿Qué hay de nuevo sobre los biomarcadores en urticaria crónica espontánea? Revisión de la literatura de los últimos años. Parte 2: biomarcadores actuales y futuros;Piel;2023-08

5. Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria;International Journal of Molecular Sciences;2023-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3